Activation Capital, the operating name of the Virginia Biotechnology Research Partnership Authority, today announced an expansion of its Bio+Tech Center to support the continued growth of life sciences entrepreneurship across the region.
Activation Capital today announced enhancements to Frontier BioHealth, building on the program’s successful 2024 launch and inaugural cohort while reinforcing its broader continuum of life sciences entrepreneurship programs designed to help science-driven companies progress toward commercialization and investor readiness.
October marked the kickoff of Activation Capital’s new Basecamp program. Basecamp is designed to provide aspiring life sciences entrepreneurs with the knowledge and tools needed
Nearly 400 guests took a break and headed to the area around VCU’s Larrick Center to enjoy the VA Bio+Tech Park Summer Festival presented by
Michael Steele took the helm as Activation Capital’s President and CEO in August. A Virginia native, he returned to the Commonwealth after more than two
Sparks were indeed flying at the BioSpark pitch event recently held at CvilleBioHub. SalivIQ, a former participant in Activation Capital’s pre-accelerator program Start-the Journey, presented their Strep A diagnostic test. Strep A is the only saliva-based test for strep throat infections, eliminating the need for follow-up throat cultures and allowing for antibiotics to be prescribed appropriately.
Perfusion Medical, a member of Activation Capital, won the pitch competition at the BioHealth Capital Region Forum. Known as the “Crab Trap” the pitch competition took place as part of the annual event that brought together nearly 1,000 government officials, academic leaders, and industry executives from Maryland, Virginia, and the District of Columbia.
The Virginia Biotechnology Research Partnership Authority (doing business as Activation Capital) announced today that it has appointed Michael Steele as president and chief executive officer.
Tympanogen, a medical device company and member of Activation Capital, is working to go to market with a gel patch to repair perforated eardrums. The
A capacity crowd filled Bio+Tech Center as members of the life sciences community from across the Richmond-Petersburg region came together for the most recent Biotech
